Vident Advisory’s ICU Medical ICUI Stock Holding History

Vident Advisory’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,942	Closed	-$270K	–	1659
2025 Q1	$270K	Buy	+1,942	New	+$301K	﹤0.01%	1315

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vident Advisory's ICUI Position: Q2 2025 in Review

Vident Advisory sold out of ICU Medical (ICUI) in Q2 2025, closing a stake of 1,942 shares — an estimated $270K sold.

Vident Advisory first reported a position in ICUI in Q1 2025 and held it in 1 quarter. The position peaked at $270K in Q1 2025. 271 funds tracked by Wall St. Rank hold ICUI as of Q2 2025.

Vident Advisory reported no remaining ICU Medical position as of Q2 2025 after selling out during the quarter.
Vident Advisory sold 1,942 ICU Medical shares in Q2 2025, an estimated $270K.
Vident Advisory first reported a position in ICU Medical in Q1 2025 and held it in 1 quarter.
Vident Advisory's ICU Medical position peaked at $270K in Q1 2025.
271 funds tracked by Wall St. Rank held ICU Medical as of Q2 2025.

Based on Vident Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.